Genmab Announces Financial Results for the First Nine Months of 2016 and Improves 2016 Financial Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. ACN
5. IBM
6. SPY
7. TSLA
8. DPZ
9. NVDA
10. PRIM

Go back to Genmab Announces Financial Results for the First Nine Months of 2016 and Improves 2016 Financial Guidance

Genesis HealthCare (GEN) Tops Q3 EPS by 12c; Guidance Reaffirmed

November 4, 2016 8:11 AM EDT

Genesis HealthCare (NYSE: GEN) reported Q3 EPS of ($0.28), $0.12 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.39 billion.Genesis HealthCare reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

... More